articleJNCI Journal of the National Cancer InstituteDec 16, 2003BRONZE OA

Determinants of BRAF Mutations in Primary Melanomas

University of California, San Francisco · Memorial Sloan Kettering Cancer Center · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

The RAS/mitogen-activated protein kinase pathway sends external growth-promoting signals to the nucleus. BRAF, a critical serine/threonine kinase in this pathway, is frequently activated by somatic mutation in melanoma. Using a cohort of 115 patients with primary invasive melanomas, we show that BRAF mutations are statistically significantly more common in melanomas occurring on skin subject to intermittent sun exposure than elsewhere (23 of 43 patients; P

No related works found for this paper.